Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A tissue slide in a dimly lit pathology lab, showcasing the PD-L1 biomarker analysis.

May 28, 2026

Leica Biosystems, Indica Labs, And Lunit Advance AI Powered Digital Pathology For PD L1 Biomarker Analysis

Leica Biosystems, Indica Labs, and Lunit are collaborating to enhance AI-driven digital pathology, specifically for PD-L1 biomarker analysis, aiming to streamline and standardize pathology workflows in precision oncology research.The partnership builds on an existing collaboration between Leica Biosystems and Indica Labs, now incorporating Lunit's advanced AI capabilities. This integration is set to enhance the quantification of PD-L1 and other immunohistochemistry biomarkers, providing a more c
A close-up of a cell culture dish in a lab setting, with a pipette above it.

May 28, 2026

Pamela Carroll ’85 uses AI in biotechnology to tackle formerly “undruggable” drivers of disease

Pamela Carroll, a 1985 graduate of Saint Michael’s College, is pioneering the integration of artificial intelligence (AI) in biotechnology, focusing on previously "undruggable" disease drivers. Her career trajectory, which includes significant roles in both research and business, highlights the transformative potential of AI in drug discovery and development.Carroll's journey began at the National Cancer Institute, where her fascination with cell biology took root. This interest propelled her th
A minimalist illustration of a test tube with green liquid on a dark background.

May 28, 2026

Cypher AI: $2 Million Seed Raised To Build AI-Native Infrastructure For Life Science R&D

Cypher AI has successfully secured $2 million in seed funding to advance its AI-native infrastructure aimed at revolutionizing life science research and development. The funding round was led by MaC Venture Capital, with contributions from several other investors, indicating strong market interest in innovative solutions for the biotech sector.Founded in 2025 by Yaoyu Yang, Cypher AI aims to transform the current fragmented and outdated systems used in life science R&D. The company is developing
A minimalist illustration of a rocket and satellite in outer space

May 28, 2026

From biotech to orbit: Rocket One’s AI and space rebrand sends shares flying

Rocket One Inc, formerly known as Hoth Therapeutics, has seen a significant share price increase of nearly 40% following its recent rebranding to focus on AI and space technologies. The company is pivoting from its original biotech roots to explore opportunities in AI infrastructure, semiconductor technologies, and space-based AI systems for satellites. This strategic shift is part of a broader trend where companies, especially smaller firms, rebrand to align with current investment trends, such
A minimalist illustration of a pill on a dark background.

May 28, 2026

How pharma and startups are working together for AI success

The PharmStars Pharmtech Innovation Summit highlighted essential strategies for collaboration between pharmaceutical companies and startups in developing AI solutions.During the summit, industry leaders emphasized that successful partnerships require more than just effective technology. Key factors include having internal advocates, clear performance indicators, and a well-defined strategy for transitioning from pilot projects to full-scale implementations. Startups must approach pharma relation
A pill bottle on a desk in a dimly lit office

May 28, 2026

Solstice Secures $21M for AI-Native Pharmaceutical Marketing Platform

Solstice, an AI-driven pharmaceutical marketing platform, has raised $21 million in Series A funding led by Transformation Capital, increasing its total funding to about $25 million. This investment aims to enhance its technical infrastructure and expedite its market entry strategies.The company addresses significant delays in pharmaceutical marketing, where the review process for marketing materials can take up to three months due to stringent medical, legal, and regulatory (MLR) checks. By int
Minimalist illustration of a prostate gland and biomarker icon

May 28, 2026

Myriad Genetics Inc stock (US62855J1043): Prolaris AI launch lifts focus

Myriad Genetics Inc. is generating renewed interest among investors following the announcement of its Prolaris + AI Test, set to launch this month. The stock was noted at $3.93, reflecting a 2.1% increase after the May 26 update.The Prolaris + AI Test represents a significant advancement in prostate cancer surveillance by integrating biomarker data with AI-driven pathology. This launch is particularly noteworthy as it positions Myriad Genetics within the competitive landscape of specialty diagno
A minimalist illustration of a pill on a solid background.

May 28, 2026

Solstice: $21 Million Series A Raised To Accelerate Pharma Commercialization

Solstice, an AI-driven marketing agency, has successfully raised $21 million in Series A funding, aimed at enhancing the commercialization processes for pharmaceuticals. This funding round, led by Transformation Capital, brings the company's total funding to around $25 million.This new investment will facilitate Solstice's expansion into the market, drive product development, and enhance team capabilities in both product and customer-facing roles. The agency is dedicated to streamlining the comm
A dual glucose-ketone sensor on a wooden table in a clinical setting.

May 28, 2026

Abbott Laboratories stock (US0028241000): regulatory clearances for AI cardiology and glucose-ketone

Abbott Laboratories has recently secured regulatory approvals for two significant digital health innovations: an AI-assisted coronary imaging platform and a dual glucose-ketone sensor, enhancing its portfolio in cardiology and diabetes care.The Ultreon 3.0 platform is designed to assist physicians during coronary stent procedures by integrating imaging and data-driven insights, while the Libre Duo sensor aims to provide comprehensive monitoring for diabetes patients by tracking both glucose and
A minimalist representation of a molecular structure symbolizing beauty innovation.

May 28, 2026

Natura Partners with AI Biotech Platform to Shape Longevity-Driven Beauty Innovation

Natura has entered a strategic partnership with Debut, an AI-driven biotechnology leader, to develop a new longevity ingredient complex aimed at revolutionizing beauty products. This collaboration seeks to leverage Debut's advanced AI technology in conjunction with Natura's extensive experience with Amazonian biodiversity to create a clinically validated ingredient that enhances skin longevity.Debut's innovative approach involves using AI to screen an extensive database of 96 billion molecular s
A test tube with protein solution in a dimly lit lab

May 28, 2026

Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications

Sino Biological's innovative cell-free protein synthesis technology has been pivotal in a recent study conducted by Tencent AI for Life Sciences Lab, as published in *Nature Communications*. This collaboration highlights the integration of AI in protein design, enabling the rapid validation of proteins that exhibit enhanced activity, stability, and multifunctionality.The study addresses a significant challenge in protein engineering: the transition from AI-generated amino acid sequences to funct
A printed healthcare provider directory on a wooden desk in a modern office.

May 28, 2026

H1 Receives $40M Investment in Round Led by CVS Health Ventures

H1, a company focused on enhancing healthcare operations through AI, has secured a significant $40 million investment led by CVS Health Ventures. This funding aims to bolster their ongoing initiatives to improve healthcare provider connections and streamline patient access to care.The investment from CVS Health Ventures, which is dedicated to fostering healthcare innovation, follows a series of successful collaborations between the two entities. Notably, they have developed an AI model that sign